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Granularity DAGUnderstanding causal relationships among large numbers of variables is a fundamental goal of biomed-
ical sciences and can be facilitated by Directed Acyclic Graphs (DAGs) where directed edges between
nodes represent the influence of components of the system on each other. In an observational setting,
some of the directions are often unidentifiable because of Markov equivalency. Additional exogenous
information, such as expert knowledge or genotype data can help establish directionality among the
endogenous variables. In this study, we use the method of principle component analysis to extract
information across the genome in order to generate a robust statistical causal network among
phenotypes, the variables of primary interest. The method is applied to 590,020 SNP genotypes measured
on 1596 individuals to generate the statistical causal network of 13 cardiovascular disease risk factor
phenotypes. First, principal component analysis was used to capture information across the genome.
The principal components were then used to identify a robust causal network structure, GDAG, among
the phenotypes. Analyzing a robust causal network over risk factors reveals the flow of information in
direct and alternative paths, as well as determining predictors and good targets for intervention. For
example, the analysis identified BMI as influencing multiple other risk factor phenotypes and a good
target for intervention to lower disease risk.
 2016 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Interindividual variation in disease susceptibility is influenced
by genetic variants, which can be organized into a defined biologic
pathways or data-driven associative networks [1]. By identifying
variables correlated with the primary endpoint of interest, we
are able to classify individuals and predict future disease. Going
beyond partial correlations and evaluating causal relationships
among variables plays an essential first step in risk prediction,
thereby promoting more efficacious treatment of current disease
and prevention of future disease. By changing the level of a causal
variable (e.g. LDL-cholesterol levels), we are able to change the risk
of future disease (e.g. coronary heart disease), which may not be
the case for mere associated variables (e.g. HDL-cholesterol levels)
[4]. In the case of a randomized intervention, such as a clinical trial,
identification of causation is conceptually straight forward. How-
ever, in observational studies, which represent the majority of
most large-scale epidemiologic studies, causal inference is morecomplex. In most applications, especially ‘‘big data” applications,
causal inference is embodied in Directed Acyclic Graphs (DAGs),
where any inference is based on an estimated graph (i.e. nodes
and edges). DAGs are illustrations of causal relationships among
the variables. Mendelian randomization is an established approach
to identify causal relationships [5–8] and it is natural in a biomed-
ical setting to integrate genomics and phenotypic information to
help establish directionality within a network of phenotypes. We
apply this technique in large data sets from different granularities
to achieve robust causal graphs (i.e. DAGs). In the present context,
granularities are defined as hierarchical levels with different quid-
dity that the causal relationship between them is known, e.g. they
are reflecting different levels of biologic organization and measure-
ment (genomic and phenotypic). In the application shown here, we
use data from a deeper granularity, the genome, to generate a
robust statistical causal network among 13 risk factor phenotypes.
Inclusion of genotypes in the analysis of phenotypes (e.g. plasma
glucose levels) provides two advantages: first, genotypes are
assumed to be measured without error, and second, there is a
natural order between these granularities (genome variation ?
phenotype variation; G ? P) and this knowledge helps identify
robust directionality in the upper granularity.
 :                   or             
 DAG A DAG B DAG C
Fig. 1. DAG A is a representation of three connected variables as well as the
knowledge about direction of the effect between two granularities where variable
X1 is from a deeper granularity. DAG B and DAG C represent direction identification
based on analysis of data.
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directionality that is less susceptible to confounding. Previous
applications in data integration using gene expression data and
genotypes have followed a similar logic [9–12]. For example,
Mehrabian et al. [9] integrated genotypic and phenotypic data in
a segregating mouse population to generate causal relationships.
Aten et al. [11] introduced an algorithm to estimate directionality
among nodes in a DAG by applying information from selected sin-
gle nucleotide polymorphisms (SNPs). In this study, we apply the
concept of granularity in a comprehensive manner and extract
information from a deeper granularity, here the genome, to achieve
a robust causal network among variables of interest in the upper
level of granularity, here cardiovascular risk factor phenotypes.
To go beyond using a sample of SNPs, which are incomplete and
may introduce instability in the study results [13], the method of
principal components is used to extract information across the
genome. Integration of genome information embedded in the dee-
per granularity and captured using principal component analysis
with phenotype information in the upper granularity results in a
robust causal network among the phenotypes, and we call this
algorithm Granularity Directed Acyclic Graph (GDAG).
We first briefly review the theory of graphical causal inference
and introduce the granularity framework and the GDAG algorithm.
The utility of this approach is introduced by application to a data
set including 13 cardiovascular disease risk factors and 590,020
SNP genotypes measured on 1596 individuals and then the esti-
mated structure is further interpreted. Use of information from
the genome level of granularity allowed us to robustly generate
the statistical causal network among the phenotypes. A discussion
of the GDAG algorithm and the results is provided.
2. Background
Assume a DAG D = (v, e) where v is a set of nodes with p ele-
ments which corresponds to a set of p random variables and e is
a set of edges which connect the nodes and shows the partial cor-
relation between two corresponding variables. The existence of a
directed edge between two nodes shows the causal relationship
between the corresponding variables. Assume P is a joint probabil-
ity distribution over the variables corresponding to the nodes in
DAG D = (v, e). The underlying assumption for a DAG is the Markov
condition is satisfied over D and P [14]: every variable Yi, i e v is
independent of any subset of its predecessors conditioned on a
set of variables, corresponds to parents/immediate causes of node
i,
Yi ? fYk; i&k 2 v n paðiÞgjYpaðiÞ;
where Yk occurs before Yi and parental set paðiÞ = paD(.) denotes the
set of parents of node i relatives to the underlying structure of DAG
D. For j e pa(i), we denote j? i or .
A topology or skeleton of a DAG is a graph without direction and
is obtained by identification of conditional (in)dependencies, see
section ‘‘Identification the Topology of Nodes” below. Identification
of directions is however a challenging problem due to the Markov
equivalent property of observational data. Analysis of data in the
upper granularity can identify only v-structures, two nonadjacent
nodes pointing inward toward a third node. A complete assess-
ment of directionality (i.e. statistical causal relationships) usually
cannot be determined from such data alone, resulting in Markov
equivalent DAGs [15,16]. Different DAGs on the same set of nodes
are Markov equivalent (ME DAGs) if and only if they have the same
topology and the same v-structures [17]. When the number of
nodes grows, the number of ME DAGs can grow super-
exponentially [18]. Complete determination of directionality over
the corresponding set v is not, however, possible in most of cases.3. The GDAG method
Identifying robust and complete directionality and showing
flow of information is a difficult task, but can be facilitated by inte-
gration of different data types (i.e. granularities) where we know
the direction of effect is from one granularity to the other. Assume
we are seeking a DAG between two phenotypes Y1 and Y2. For this
example, assume genome-wide information, related to the set (Y1,
Y2) is captured in the variable X1. Based on the results of an analysis
assessing conditional independencies, we find that X1 is correlated
to Y1 and is independent of Y2 given Y1, by notation Y2\X1|Y1. Since
genome sequence variation is a causal factor in phenotypic differ-
ences (and not the other way around), the direction of the effect is
from X1 to Y1, as shown in DAG A in Fig. 1. Knowing the relationship
between X1 and Y1 helps generate the directionality between Y1
and Y2 based on the property Y2 ? X1jY1, and the direction shows
the flow of information is from Y1 to Y2, as shown in DAG B in
Fig. 1. If we obtain by analysis of the data,
then the direction of effect would be from Y2 to Y1, as shown in
DAG C in Fig. 1, which represents a v-structure at Y1.
To identify the direction among three variables in ME DAGs
, we need to have at least two variables from the
genome (i.e. a lower level of granularity, where G? P) influencing
Y1 and Y2 or one variable from the genome influencing Y3. By inte-
grating multi-omics data from different granularities, we are able
to derive causal inference that is less susceptible to confounding
and, as a result, estimate causal networks robustly and uniquely.
Partial information from a deeper granularity creates weak instru-
mental variables and may result in unstable structures in the upper
granularity [13], and we may not be able to find a genome variable
strongly associated with every phenotype under study [19]. There-
fore, we go beyond inclusion of a sample of SNP marker genotypes
and extract comprehensive information across the genome by
application of principal component analysis (PCA) to reduce the
dimensionality of the data while retaining most of the variation
in the data set. Since PCA is an unsupervised approach, it avoids
increasing false discovery using the same data twice. The steps of
the GDAG algorithm are summarized as follows:
The GDAG Algorithm: Steps to identify a Granularity Directed
Acyclic Graph (GDAG) over a set of variables of interest, Y,
using data from a deeper granularity, X
1. Extract genome information by principal component
analysis. Select the principal components responsible for a
majority of genome variation, set X.
2. Estimate a topology over sets Y and X.a
3. If a variable in set X is linked to a variable in set Y, draw an
arrow from the former to the latter.
4. Use the established directions from step 3, generate other
directions using partial correlations recorded in step 2.b
5. If there is an undirected link between Ys, use rules in [20] to
identify directionality.c
a Topology estimation is detailed in the following section.
b Presented at the beginning of this section.
c The supplementary information provides further details.
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is sparse. A sparse network is a network with fewer numbers of
links than the maximum possible number of links within the same
network [21]. Under the sparsity assumption, the run-time of the
algorithm is reduced to a polynomial and as a result the number
of nodes can grow with the sample size. This assumption is reason-
able and is often considered in most biomedical applications [22–
25].
When applying the GDAG algorithm, we are primarily inter-
ested in the causal relationships among nodes in the upper granu-
larity, not among nodes in the deeper granularity or the
relationship between the deeper and upper granularities. In the
current application, genome information summarized by PCAs is
applied to identify a robust statistical causal network structure
among cardiovascular risk factor phenotypes in upper granularity.
In genetics and epidemiology, application of PCA for summarizing
genome information is frequent [e.g. 26–29].4. Identification the topology of nodes
In this manuscript, generating the basic topology among nodes
and then assessing directionality are carried out by finding condi-
tional independencies in the framework of data integration. One
statistical approach to estimate conditional independencies under
a Gaussian assumption is assessing partial correlations [30–32].
Conditioning only on one variable, the partial correlation is defined
as
qyiyj yk ¼
qyiyj  qyiykqyjykﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð1 q2yiyk Þð1 q2yjyk Þ
q ;
where ryiyj ¼ covðyi; yjÞ=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
varðyiÞvarðyjÞ
q
is the Pearson product-
moment correlation coefficient. Fisher’s Z transform is used to
assess the statistical significance of the sample correlation coeffi-
cient, r. If the partial correlation between two variables Yi and Yj
given variables corresponding to a subset s#v n fi; jg is not deter-
mined to be significantly different from zero at some significance
threshold, then the corresponding nodes i and j are not connected
with an edge. On the other hand, there is an edge between nodes
i and j if and only if given all subsets s#v n fi; jg;Yi and Yj are
significantly correlated (see [33] prop. 5.2). Assessing all partial
correlations in the case of multivariate normal distribution to
estimate conditional independencies is computationally unfeasible.
Therefore, a sparsity assumption is employed, meaning that each
node is connected to only some but not all of the nodes in the
network.4 v-structures 3 v-structur
Fig. 2. Three truth sets. The underlying graph on the left has 4 v-structures (at nodes 4, 5
v-structures (at nodes 7 and 8). The nodes that v-structures are formed in are highlight5. Results
5.1. Application to simulated data
To evaluate the properties of the GDAG algorithm, we used sim-
ulated data. We estimated the simulated DAG without genomic
information and separately with the GDAG algorithm incorporat-
ing the genomic information. We then compared the frequency
of false discoveries (FD), which are the number of wrong direc-
tions, and non-discoveries (ND), which are the number of non-
directed edges, estimated by each method. Since the performance
of the algorithms depends on the number of v-structures in the
underlying causal graph, we considered DAGs with different num-
bers of v-structures. The underlying models of the simulations are
depicted in Fig. 2.
In order to have genotype data with a realistic linkage disequi-
librium structure, we generated 10,000 SNPs for 2000 individuals
on the basis of a coalescent model that mimics the linkage disequi-
librium (LD) (i.e. non-random association of alleles at different loci)
pattern, local recombination rate and the population history of
African American and European American using a previously vali-
dated demographic model [34].
Phenotype values were generated using the structural model
Zi ¼
Xi1
j¼1
kijZj þ
Xq
k¼1
cikXk þ ei;
for j < i, where the phenotypes (Zj) in the model are compatible with
the graphs in Fig. 2. For each scenario, SNPs were selected randomly
from the larger set of generated SNPs. The ei in the model was
assumed to be Gaussian with unit variance. The value of non-zero
genome effects were randomly sampled from a Uð0:9;0:5Þ and
U(0.5, 0.9) and the value of the non-zero phenotype effects were
sampled from a uniform Uð1:9;1:0Þ and Uð1:0;1:9Þ. The values
of these extreme points were based on preliminary analyses. While
other studies such as [32] considered only positive effects, we con-
sidered both negative and positive effect sizes.
The simulated data were analyzed considering only the pheno-
typic data using the PC-algorithm [35] which is implemented with
polynomial complexity in high-dimensional sparse setting [32].
The simulated data were also analyzed using the GDAG algorithm
based on both phenotypic and genomic data. To apply the GDAG
algorithm, we extended the PC-algorithm to analyze data from dif-
ferent granularities. We extracted information from the generated
SNPs using principal component analysis and selected the first 110
principal components responsible for almost 90% of variation to
form the set X in the GDAG algorithm. Result of the comparisones 2 v-structures
, 7, and 8), the middle has 3 v-structures (at nodes 4, 5, and 8), and on the right has 2
ed in the graphs.
Fig. 4. Mean FDRs for different sample sizes and different significant levels:
a = 0.01, the red line, and a = 0.001, the black line.
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fifty repetitions is summarized in Fig. 3, which shows the number
of false discoveries (FD) and non-discoveries (ND) under different
scenarios.
The GDAG algorithm has fewer FDs and NDs compared to a sim-
ple DAG application without the genome information. As can be
seen in Fig. 3, the performance of the PC-algorithm is improved
dramatically by adding information from a deeper granularity.
There have been other attempts to improve the PC-algorithm’s
characteristics. For example, de Campos and Castellano [36]
improved the PC-algorithm by employing three types of structural
restrictions, and Shojaie and Michailidis [25] achieved better per-
formance using a penalization approach.
5.2. The GDAG performance for different numbers of samples and
significance levels
The GDAG algorithm can generate directionality robustly
because it leverages information from a deeper granularity. Here,
we examine the performance of the GDAG algorithm for different
numbers of observations and two significance levels. We simulated
different number of individuals and 40 replicates for each sample
size for an underlying network with directionality. Using data from
a deeper granularity, the GDAG algorithmwas used to generate the
topology and directionality for each replication. Therefore, when
assessing the GDAG performance across different scenarios, show-
ing either the false discovery rate (FDR) or true discovery rate are
sufficient. The mean FDRs across the 40 replicates for each sample
size were calculated. A smooth line over mean of FDRs is depicted
in Fig. 4. The red line shows the mean FDRs at the significance
a = 0.01 and the black at a = 0.001.
Examination of the FDR rate in Fig. 4 indicates unsatisfactory
rates of false discovery at small sample sizes (e.g. <600 for
a = 0.001 and <1200 for a = 0.01) and satisfactory rates at larger
sample size at both significance levels. For sample sizes between
600 and 1200, a = .001 provides more reliable result than a = .01.
5.3. Application to genotype and risk factor data
As an application of the GDAG algorithm, we identified causal
relationships among 13 chronic disease risk factor phenotypes:
BMI (body mass index), SB (systolic blood pressure), DB (diastolic
blood pressure), FG (fasting glucose), FS (fasting insulin), HDL (high
density lipoprotein), LD (low density lipoprotein), TRIG (triglyc-
eride), TC (total cholesterol), FIBR (Fibrinogen), PLT (Platelet
count), as well as electrocardiogram measurements QT and QRS.Fig. 3. Comparison of the performance of the GDAG and PC algorithms by comparing
structures.The data set includes 590,020 measured genotypes in sample of
1596 non-Hispanic white individuals from the National Heart Lung
and Blood Institute (NHLBI) GO-ESP, which is an ancillary study of
the Atherosclerosis Risk in Communities (ARIC) study [37], the Car-
diovascular Health Study (CHS) [38], and the Framingham Heart
Study [39]. The data were obtained from dbGAP [40], and this anal-
ysis is part of ongoing studies having local Institutional Review
Board approval. The following steps were undertaken in order:
1. Prior to calculation of the principle components, we identified a
subset of informative SNPs using hierarchical clustering and the
r2 measure of linkage disequilibrium, where r2 is the square of
correlation between two SNPs [41].
2. Since chromosomes are assumed to be independent, we applied
principal component analysis over each chromosome sepa-
rately and selected the first principal components responsible
for approximately 90% of the variation. Over all of the chromo-
somes, 586 principal components were selected.
3. The topology of the network was determined over the 13 risk
factor phenotypes and the principal components. 130 genome
wide principal components remained in the model at significant
level 0.01.False Discoveries (FD) and Non Discoveries (ND) under different numbers of v-
Fig. 5. A robust GDAG among 13 cardiovascular risk factor phenotypes using
information across the genome embodied in 130 principal components remained in
the model. Only some of them are depicted here (numbered nodes) so as to better
highlight the structure among the phenotypes.
118 A. Yazdani et al. / Journal of Biomedical Informatics 60 (2016) 114–1194. The direction of effect was assumed to be from the genome-
wide principal components to the risk factor phenotypes (and
not the other way around).
5. Use partial correlations to estimate the Markov properties
among the risk factor phenotypes and directions in step 4, the
directionality of the network is determined. Details can be
found in the supplementary materials.
The resulting GDAG among the risk factor phenotypes is shown
in Fig. 5.
As was shown in the simulated data, use of information from
the genome embedded in the principal components allowed us
to estimate the causal network among the phenotypes. Some of
the relationships in Fig. 5 are expected, such as those among the
lipid phenotypes. The analysis identified a causal link between
BMI and HDL-cholesterol and an indirect effect of BMI on triglyc-
erides. The relationship between fibrinogen and platelets under-
scores the important role of fibrinogen in platelet aggregation
and function [42]. It is important to note the effect of BMI through-
out the network.6. Discussion
DAGs are illustrations of causal relationships among a set of
related variables. To definitively identify causal relationships,
interventions are required. However, interventions, even in some
parts of the graph, are not possible in most human observational
studies. Data analysis alone does not robustly identify causal rela-
tionships, except in very special cases for non-Gaussian distribu-
tions [43]. As shown here, application of domain expert
knowledge and data from another granularity is helpful for identi-
fying causal networks, including the direction of arrows and esti-
mating the magnitude of effect sizes. In a granularity framework,
we take advantages of genotype information to identify a robust
statistical causal network structure among phenotypes (i.e. GDAG),
which provides a high degree of certainty about finding causal
relationships. Any algorithm for DAGs can be extended in the gran-
ularity framework to be able to achieve causal inference that is less
susceptible to confounding by hidden variables and, as a result,
estimate robust statistical causal networks which are wellanchored to domain knowledge. In previous applications, a priori
biologic candidate gene variation has been used to analyze pheno-
types [11], but a comprehensive approach to the concept of gran-
ularity has not been used. Leveraging eQTLs identified from
previous association studies to reduce the number of Markov
equivalence classes among phenotypes is well-established, e.g.
[12] but distinct from the concept of granularity. To the best of
our knowledge, there is no report using PCAs derived from
genome-wide SNP information to identify the causal network
structure among phenotypes. In the proposed granularity frame-
work, the domain knowledge ‘‘genome variation causes pheno-
typic differences” is used along with objective dependencies in
the data to estimate causal relationships.
The concept of granularity can be applied to reduce the running
time of the GDAG algorithm. Since the primary interest is generat-
ing a causal network structure over the variables Y in the upper
level of granularity, the topology of the causal network can be esti-
mated only over the variables Y. After the topology is established,
the GDAG algorithm seeks partial correlations between any two
variables, one from X and the other from Y. Since the variables in
set X, the genome-wide principal components, are independent
of one another, the GDAG algorithm does not require estimating
the partial correlations between the Xs. This results in further
reduction of the running time.
To implement the granularity framework, we extended the
Peter and Clark (PC) algorithm because it is computationally feasi-
ble and often fast for sparse problems having many nodes (vari-
ables) [32]. This method can be applied to generate network
structures among many variables and reveal patterns in complex
systems. A robust statistical causal network reveals patterns in
the underlying structure, thereby identifying good targets for
intervention and prediction. The total effects among phenotypes
can be estimated by structural equations while a sufficient set of
confounders identified graphically are in the model [44]. We
applied the GDAG algorithm to 13 risk factor phenotypes and
genome-wide principal components as the deeper granularity.
Visualization of the phenotype GDAG shown in Fig. 5 provides
opportunities for improved disease prediction and identifying tar-
gets for risk factor intervention. Nodes with a high in-degree (i.e.
number of arrows pointing into a node) correspond to variables
influenced by multiple other risk factors. These nodes may be good
predictors of disease since they capture information from multiple
risk factors. On the other hand, nodes with a high out-degree (i.e.
number of arrows pointing out of a node) correspond to variables
having influences on multiple other risk factors. These nodes may
be good intervention targets to lower risk and influence clinical
outcomes. For example, according to the GDAG in Fig. 5, a good dis-
ease predictor may be fibrinogen (FIBR) since it is influenced by
multiple other risk factors. BMI may be a good intervention target
since it has a high impact on the other risk factor levels, such as fib-
rinogen, HDL, glucose, and insulin. Changes in BMI are predicted to
yield changes in the majority of the network of risk factors. In con-
clusion, generating a robust statistical causal network among risk
factor phenotypes and using this directionality, we are able to
identify good candidates for future manipulation.Disclaimer
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